Abstract
BackgroundThe use of TNF-inhibitors and/or the IL-6 receptor antagonist, tocilizumab, in rheumatoid arthritis (RA) have pleiotropic effects that also involve circulating B-cells.ObjectivesThe main goal of this study was to assess...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have